Q4 2023 Holdings
Filed 2024-02-15 | 52 holdings | $101.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| DR Reddys Labs LTD(RDY) | ADR | 256135203 | $6.3M | 90,000 | 6.2% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $5.7M | 9,700 | 5.6% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $5.5M | 186,900 | 5.5% |
| The Cigna Group(CI) | COM | 125523100 | $4.6M | 15,300 | 4.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $4.4M | 111,300 | 4.4% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $3.5M | 203,300 | 3.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $3.3M | 72,203 | 3.3% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $3.3M | 173,500 | 3.3% |
| Dexcom Inc(DXCM) | COM | 252131107 | $3.1M | 24,828 | 3.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $3.1M | 13,202 | 3.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $2.9M | 34,908 | 2.9% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $2.8M | 73,158 | 2.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $2.8M | 68,100 | 2.7% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $2.8M | 91,800 | 2.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $2.6M | 65,113 | 2.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $2.3M | 12,800 | 2.3% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $2.3M | 37,900 | 2.3% |
| Penumbra Inc(PEN) | COM | 70975L107 | $2.2M | 8,553 | 2.1% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $2.1M | 6,358 | 2.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $2.1M | 8,200 | 2.1% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $2.0M | 28,300 | 2.0% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $1.9M | 45,467 | 1.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.9M | 61,500 | 1.9% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $1.8M | 29,100 | 1.8% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $1.8M | 105,500 | 1.8% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $1.7M | 84,400 | 1.7% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $1.6M | 223,300 | 1.6% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $1.6M | 3,900 | 1.6% |
| Immatics N.v(IMTX) | SHS | N44445109 | $1.4M | 129,900 | 1.4% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $1.3M | 36,384 | 1.3% |
| Geron Corp(GERN) | COM | 374163103 | $1.3M | 607,500 | 1.3% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $1.2M | 693,300 | 1.2% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $1.2M | 125,900 | 1.2% |
| Natera Inc(NTRA) | COM | 632307104 | $1.2M | 18,650 | 1.2% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $1.1M | 135,596 | 1.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.1M | 46,700 | 1.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $933.9K | 15,896 | 0.9% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $897.9K | 49,580 | 0.9% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $764.0K | 35,257 | 0.8% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $762.2K | 4,000 | 0.8% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $755.0K | 83,987 | 0.7% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $738.7K | 75,300 | 0.7% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $714.6K | 27,600 | 0.7% |
| Sutro Biopharma Inc | COM | 869367102 | $658.9K | 153,600 | 0.7% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $610.1K | 26,400 | 0.6% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $588.4K | 9,744 | 0.6% |
| Procaps Group SA(PROCF) | SHS | L7756P102 | $516.5K | 126,901 | 0.5% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $433.9K | 7,249 | 0.4% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $411.4K | 40,974 | 0.4% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $275.2K | 118,100 | 0.3% |